Form 4 for VCEL Vericel Corp

Accepted 2022-02-08 00:00:00 ET · period of report 2022-02-06 · accession 0001593968-22-000423 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-02-08	2022-02-06	VCEL	Hopper Jonathan Mark	Chief Medical Off	F - Tax	$33.91	-310	44.0K	-0.7%	-$10.5K
D	2022-02-08	2022-02-06	VCEL	Hopper Jonathan Mark	Chief Medical Off	M - OptEx	$0.00	+650	44.4K	+1%	$0
D	2022-02-08	2022-02-06	VCEL	Hopper Jonathan Mark	Chief Medical Off	M - OptEx	$33.91	-650	650	-50%	-$22.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-02-06	F	D	310	$33.91	44,044	D	—	—	(F2) These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of Restricted Stock Units.
2	Common	Common Stock	2022-02-06	M	A	650	$0.00	44,354	D	—	—	(F1) The shares of common stock were acquired by the Reporting person as a result of the vesting of RSUs granted to the Reporting Person on February 6, 2019. The remaining RSUs will vest on February 6, 2023.
3	Derivative	Restricted Stock Unit	2022-02-06	M	D	650	$33.91	650	D	— · — to —	650 Common Stock	(F3) Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. (F1) The shares of common stock were acquired by the Reporting person as a result of the vesting of RSUs granted to the Reporting Person on February 6, 2019. The remaining RSUs will vest on February 6, 2023. (F4) No expiration date for this type of award.